首页|期刊导航|中西医结合慢性病杂志|姜黄素抗肝癌的多维探索:化学特征、分子机制与联合用药

姜黄素抗肝癌的多维探索:化学特征、分子机制与联合用药OA

Multidimensional Exploration of Curcumin in Hepatocellular Carcinoma Therapy:Chemical Characteristics,Molecular Mechanisms,and Combination Therapy

中文摘要英文摘要

肝细胞癌(hepatocellular carcinoma,HCC)是一种高度恶性的肿瘤,其发病隐匿,早期诊断困难,致死率高,严重影响患者的生活质量和生命安全.姜黄素是从中药姜黄根茎中提取的多酚类化合物,广泛应用于食品加工和医疗保健领域.近年来,随着对姜黄素研究的不断深入,其在HCC治疗中的应用受到广泛关注.姜黄素能够抑制肝癌炎症水平,通过多种途径诱导肝癌细胞凋亡,抑制肿瘤内异常血管生成,并表现出良好的抗肝炎病毒药理作用.系统综述近年来姜黄素抗肝癌的研究进展,以期为姜黄素治疗HCC的基础研究、药物开发与临床应用提供重要参考.

Hepatocellular carcinoma(HCC)is a highly malignant tumor characterized by insidious onset,difficulties in early diagnosis,and high mortality rates,which seriously affects patients'quality of life and survival.Curcumin,a polyphenolic compound extracted from the rhizome of the traditional Chinese herb turmeric,is widely used in food processing and healthcare.In recent years,with increasing research on curcumin,its application in the treatment of HCC has attracted widespread attention.Curcumin can suppress inflammatory activity in liver cancer,induce apoptosis of hepatocellular carcinoma cells through multiple pathways,inhibit abnormal intratumoral angiogenesis,and demonstrate effective antiviral pharmacological effects against hepatitis virus.This review systematically summarizes recent advances in the research on curcumin against liver cancer,aiming to provide valuable references for basic research,drug development,and clinical applications of curcumin in the treatment of HCC.

高浩莱;宋元铭;陈尚祥;王哲

辽宁中医药大学,辽宁 沈阳 110847中国医科大学,辽宁 沈阳 110122南昌大学第一附属医院,江西 南昌 330006辽宁省肿瘤医院,辽宁 沈阳 110042

医药卫生

肝细胞癌姜黄素中药炎症细胞凋亡血管生成

hepatocellular carcinomacurcumintraditional Chinese medicineinflammationapoptosisangiogenesis

《中西医结合慢性病杂志》 2026 (2)

51-56,6

国家自然科学基金地区科学基金项目(82460484)北京市希思科临床肿瘤学领航研究基金项目(Y-2019AZMS-0055)

10.26950/j.issn.2097-5031.2026.02.009

评论